BRIVLERA
Identification of Brivlera
| No description |
Google image searchProduct monograph
Active ingredient
brivaracetam, 50 MG
DIN: 02452952
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: UCB CANADA INC
Date: 02-MAY-2016
ATC:
- N03 — ANTIEPILEPTICS (ATC, ATC/DDD, )
- N03A — ANTIEPILEPTICS (ATC, ATC/DDD)
- N03AX — Other antiepileptics (ATC, ATC/DDD)
- N03AX23 — BRIVARACETAM (ATC/DDD)
